Lisa Peraza - 17 Jul 2023 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
VP, Chief Accounting Officer
Signature
/s/ Lisa Peraza
Issuer symbol
HRTX
Transactions as of
17 Jul 2023
Net transactions value
$0
Form type
4
Filing time
19 Jul 2023, 18:21:02 UTC
Previous filing
17 Jul 2023
Next filing
17 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 17 Jul 2023 Common Stock 150,000 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (07/17/2023).